Related Experiment Video
Updated: Jul 31, 2025

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
Relugolix in Clinical Practice: The Best Route for All?
Lisa M Cordes1,2, Fatima Karzai1, William D Figg1
1Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Relugolix offers an oral option for androgen deprivation therapy (ADT) in prostate cancer. This review balances its benefits against injectable ADT, considering patient factors and pharmacology.
Area of Science:
- Oncology
- Pharmacology
Background:
- Androgen deprivation therapy (ADT) is a standard treatment for prostate cancer.
- Relugolix, approved in 2020, is the first oral ADT medication.
Purpose of the Study:
- To provide a balanced discussion on the clinical benefits of oral relugolix compared to injectable ADT formulations.
- To explore patient preference, compliance, financial toxicity, and pharmacologic characteristics of relugolix.
Main Methods:
- Literature review and clinical data analysis.
- Comparative assessment of oral versus injectable ADT.
Main Results:
- Oral ADT (relugolix) offers convenience but requires careful consideration of its advantages over long-acting injectables.
- Pharmacologic properties, patient-reported outcomes, and cost-effectiveness are key factors in treatment selection.
Conclusions:
- The optimal use of relugolix in prostate cancer care depends on a comprehensive evaluation of clinical efficacy, patient-specific factors, and economic considerations.
- Further research is needed to fully elucidate the long-term impact and comparative effectiveness of oral ADT in diverse patient populations.
More Related Videos
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route

